Abstract:Omega‐3 polyunsaturated fatty acids (PUFA) influence lipid metabolism and inflammatory signaling pathways in white adipose tissue (WAT). Alpha‐linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the three primary dietary omega‐3 PUFAs that have wide‐ranging functions in humans. There is currently a limited understanding of the independent effects of individual omega‐3 PUFAs because ALA is continuously converted endogenously into EPA and DHA via the fatty acid desaturase (FADS) pathway. The fatty acid desaturase 2 gene ( Fads2 ) encodes the rate‐limiting delta‐6 desaturase enzyme in this pathway. This study examined the role of Fads2 on WAT omega‐3 PUFA metabolism and whether the consumption of a diet supplemented with menhaden oil (MD), which is rich in EPA and DHA, could rescue changes in WAT associated with a Fads2 deficiency. Weaned Fads2 knockout ( Fads2 − / −) and wild type (WT) mice were fed one of two low fat (7% w/w) AIN93G diets for 9 weeks containing either flaxseed oil + ARASCO (FD, 55% ALA) or menhaden oil (MD, 30% EPA/DHA). RT‐qPCR was used to analyze expression of genes related to PUFA metabolism. Thin‐layer and gas chromatography were used to measure fatty acid content in the phospholipid and triacylglycerol fractions in WAT. Analysis of oxylipins was undertaken using liquid chromatography–tandem mass spectrometry. Western blotting was performed for delta‐5‐desaturase (D5D) protein quantification. Fads2 −/− mice fed FD had increased expression of Fads1 and Elovl2 , and decreased expression of Elovl5 genes (p<0.05). These changes were abrogated with MD feeding. Estimated D5D activity (arachidonic acid: dihomo‐γ‐linolenic acid ratio) was increased in Fads2 −/− mice fed FD in WAT (p<0.05), but this change was not mirrored in FADS1 protein content. EPA and DHA levels were depleted in WAT of Fads2 −/− mice fed FD, as were their derived oxylipins; however, feeding Fads2 − / − mice MD restored both omega‐3 PUFA and oxylipin profiles. In conclusion, these results demonstrate that Fads2 has an important role regulating omega‐3 PUFA and oxylipin content in WAT. Moreover, changes in WAT associated with a Fads2 deficiency can be rescued with a nutritional intervention containing EPA and DHA. Support or Funding Information This work was supported by the Canadian Institutes of Health Research.

Fucoxanthin Promotes the Chain Lengthening Reaction of Polyunsaturated Fatty Acids in Vivo by Enhancing FADS2 Enzyme Activity

Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway

Fucoxanthin Improves Serum Lipids, Liver Metabolism and Gut Microbiota in Hyperlipidemia Mice

N-3 Polyunsaturated Fatty Acids in Phospholipid or Triacylglycerol Form Attenuate Nonalcoholic Fatty Liver Disease Via Mediating Cannabinoid Receptor 1/adiponectin/ceramide Pathway.

Ximenynic Acid Regulation of N-3 PUFA Content in Liver and Brain

Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism

Optimization of concentrations of different n-3PUFAs on antioxidant capacity in mouse hepatocytes

Consumption of an EPA and DHA Rich Diet Rescues Changes in White Adipose Tissue Lipid Metabolism and Oxylipin Production Induced in Fads2‐null Mice

Fads2 knockout mice reveal that ALA prevention of hepatic steatosis is dependent on delta-6 desaturase activity

Fucoxanthin Enhances the Level of Reduced Glutathione via the Nrf2-Mediated Pathway in Human Keratinocytes

Modulation of Gut Microbiota by Fucoxanthin During Alleviation of Obesity in High-Fat Diet-Fed Mice.

Fucoxanthin alleviated atherosclerosis by regulating PI3K/AKT and TLR4/NFB mediated pyroptosis in endothelial cells

Exogenous Arachidonic Acid Affects Fucoxanthin Biosynthesis and Photoprotection in Phaeodactylum tricornutum

Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.

Lipid-Lowering Bioactivity of Microalga Nitzschia laevis Extract Containing Fucoxanthin in Murine Model and Carcinomic Hepatocytes

Fucoxanthin alleviated atherosclerosis by regulating PI3K/AKT and TLR4/NFκB mediated pyroptosis in endothelial cells

Generation of Fad2 and Fad3 Transgenic Mice That Produce N-6 and N-3 Polyunsaturated Fatty Acids

Fucoxanthin's Optimization from Undaria pinnatifida Using Conventional Heat Extraction, Bioactivity Assays and In Silico Studies

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

Regulation of Δ6Fads2 Gene Involved in LC-PUFA Biosynthesis Subjected to Fatty Acid in Large Yellow Croaker (larimichthys Crocea) and Rainbow Trout (oncorhynchus Mykiss)

Protective Role of N6/n3 PUFA Supplementation with Varying DHA/EPA Ratios Against Atherosclerosis in Mice